Lipocine reports Q3 2026 results, highlights BLOOM study launch for LPCN 1154Nov 5Quarterly updateLipocine Inc.
Health Canada approves Lipocine's TLANDO for testosterone replacement therapyOct 7Regulatory decisionLipocine Inc.testosterone
Lipocine's PPD drug misses Phase 3 goal, but company cites site data anomaliesAug 4Quarterly updateLipocine Inc.